Incyte Corporation (NASDAQ:INCY) saw its stock surge 7% after the company announced that multiple research presentations, ...

Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing the investigational therapy Haduviotm (oral nalbuphine ER) for the treatment of chronic cough in patients with ...

LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) unveiled significant findings from its Phase 3 IMPALA-2 clinical trial of ...

The conference, led by Lance Becker, MD, professor in the Institute of Bioelectronic Medicine at the Feinstein Institutes, ...

Clinical validation of the Azymetric platform is demonstrated by the accelerated approval our partner Jazz Pharmaceuticals received from the U.S. Food and Drug Administration in 2024 for Ziihera® ...

Acceptance of multiple abstracts for presentation at significant medical congresses ... the 2025 Eastern Allergy Conference (EAC), to be held from May 29-June 1, 2025, in Palm Beach, Fl.; ...

Poster winners at St. Mary’s Madelia were ... Area elementary students participate in contest Schools in Watonwan County kicked off Mental Health Awareness Month with a… ...

The accepted abstracts listed below are now available online at the EHA conference website. Copies of the oral and poster presentations will be made available in the ‘Publications & Meetings ...

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced ...

June 4 at 4 p.m. Central Time The Jefferies Global Healthcare Conference 2025 in New York on Thursday, June 5 at 11:05 a.m. ET Each presentation will be webcast live and may be accessed through a ...